How to Choose the Right Candida auris PCR Assay for Your Laboratory
How to Choose the Right Candida auris PCR Assay for Your Laboratory
Blog Article
Choosing the right Candida auris PCR Assay can help laboratories simplify molecular testing workflows while considering instrument compatibility, turnaround time, sample types, and overall laboratory requirements. BioGX offers a lyophilized PCR reagent designed for validation on multiple real-time PCR platforms.
What to Consider When Choosing a Candida auris PCR Assay?
1. Multi-Platform Compatibility
Laboratories should first consider whether a Candida auris PCR Assay can be validated on their existing PCR instruments. The BioGX Candida auris PCR reagent can be validated and adapted on several platforms, including the BD MAX™ System, ABI QuantStudio™ 5, ABI 7500 Fast Dx, Bio-Rad CFX96 Touch™, Bio-Rad CFX384 Touch™, and BioGX pixl™ real-time PCR platform.
2. Simple Lyophilized Format
The BioGX Candida auris reagent is provided as a complete PCR mix in a single lyophilized tube. This format can help simplify reagent preparation and support a more straightforward laboratory workflow.
3. Fast and Cost-Effective Workflow
Turnaround time and laboratory costs are important factors when selecting a Candida auris PCR Assay. The BioGX solution is designed as an affordable molecular testing option with a fast workflow. On the BD MAX platform, the stated turnaround time is approximately 2 hours for 24 samples. After nucleic acid extraction, PCR runs on ABI or Bio-Rad platforms take approximately 2 hours for up to 96 samples.
4. Sample Type Flexibility
Laboratories should also evaluate whether the assay can accommodate the sample types relevant to their workflow. Sample types listed by BioGX for laboratory validation include:
- Urine, neat or boric acid preserved
- Swab samples collected in Copan UTM® or Copan eSwab™
- Pretreated sputum samples
- Pretreated bronchoalveolar lavage (BAL) samples
5. Positive Control Availability
Quality control materials are another consideration when evaluating a Candida auris PCR Assay. BioGX offers the BioGX Candida auris Template Control, Catalog Number 720-0173, as a positive control option.
Why Consider a Multi-Platform Candida auris PCR Assay?
A multi-platform approach can provide laboratories with flexibility when working with different real-time PCR instruments. Instead of being limited to one platform, laboratories can evaluate and validate the assay according to their existing equipment and workflow requirements.
The BioGX Candida auris PCR Assay provides a lyophilized, complete PCR mix with multi-platform availability and a workflow designed to support efficient molecular testing.
Final Considerations
When selecting a Candida auris PCR Assay, laboratories should consider platform compatibility, reagent format, sample types, turnaround time, control availability, and workflow requirements. Reviewing these factors can help laboratories identify an assay that aligns with their molecular testing needs.
Note: Sample types and assay performance should be validated by the laboratory before use according to applicable read more protocols and manufacturer instructions.
Report this page